Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery

Condition:   Obesity Interventions:   Drug: Naltrexone/bupropion;   Other: Lifestyle Sponsors:   Oslo University Hospital;   Orexigen Therapeutics, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials